Infinity Pharmaceuticals, Inc. (INFI) Stock: Why It’s Down

0

Infinity Pharmaceuticals, Inc. (INFI) is headed down in the market today. The company, focused on the biotech space, is currently priced at $1.80 after falling -5.76% so far in today’s session. In terms of biotechnology stocks, there are quite a few aspects that have the potential to lead to declines in the market. News tends to be one of the biggest reasons for the movement. Here are the recent headlines centered around INFI:

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Mar-15-19 11:37AM Infinity Inks Deal With Roche for Phase II Study of IPI-549
Mar-14-19 11:32AM Edited Transcript of INFI earnings conference call or presentation 14-Mar-19 12:00pm GMT
09:50AM Infinity Pharmaceuticals (INFI) Reports Q4 Loss, Tops Revenue Estimates
08:52AM Infinity: 4Q Earnings Snapshot
07:32AM Infinity Pharmaceuticals Reports Full Year 2018 Financial Results and Provides Company Update

Nonetheless, when making an investing decision, investors should take a look at far more than just news, this is especially the case in the generally speculative biotech sector. Here’s what’s going on with Infinity Pharmaceuticals, Inc..

Recent Moves From INFI

While a move down on a single session, like the move that we’re seeing from Infinity Pharmaceuticals, Inc. may lead to fear in some investors, that by itself shouldn’t be the reason for a decision to, or not to, invest in a stock. It is always a good idea to look at trends experienced by the stock for a period longer than a single trading session. When it comes to INFI, here are the movements that we have seen:

  • Past 5 Trading Sessions – Throughout the past seven days, INFI has seen a change in value in the amount of 20.00%.
  • Past 30 Days – The monthly performance from Infinity Pharmaceuticals, Inc. comes to 34.33%.
  • Past Three Months – Over the past three months, the stock has produced a return that comes to 44.00%
  • Past Six Months – Throughout the previous 6 months, we have seen a performance that amounts to -17.81% from the stock.
  • Year To Date – Since the the first trading session of this year INFI has generated a ROI of 52.54%.
  • Annually – Finally, over the past year, we have seen a change in the amount of -33.33% out of INFI. Over this period, the stock has sold at a high price of -38.36% and a low of 80.00%.

Key Ratios

Digging into various key ratios associated with a stock can provide prospective traders a view of how risky and/or potentially profitable a pick might be. Here are some of the key ratios to consider when looking at INFI.

Short Ratio – The short ratio is a measure of short interest. As the ratio heads up, it means that more investors have a belief that the value of the stock is going to go down. Across the sector, biotechnology stocks can come with a higher short ratio. However, we also see a lot of short squeezes in the industry. Nonetheless, in regard to Infinity Pharmaceuticals, Inc., it’s short ratio is 2.74.

Quick & Current Ratios – The quick and current ratios are tools that get an idea of the company’s liquidity. Basically, they measure the company’s abilities to pay for its debts as they mature using current assets or quick assets. In the biotech industry, several companies are reliant on continued investor support, these ratios can be damning. However, some good picks in the biotechnology space do have great quick and current ratios. In terms of INFI, the quick and current ratios work out to 7.80 and 7.80 respectively.  

Book To Share Value – The book to share value compares the value of assets owned by the company to the share price of the stock. In this particular case, the book to share value ratio works out to 0.92.

Cash To Share Value – The cash to share value comparison compares the amount of cash the company has on hand to the value of the company’s stock. Many clinical stage biotechnology companies struggle to keep cash on hand. So, if you’re looking into a stock in the biotechnology industry, this is an important ratio to consider. In this case, the cash to share value works out to 0.97.

What Analysts Think About Infinity Pharmaceuticals, Inc.

Although it’s not a good idea to blindly follow the opinions of analysts, it is a good idea to consider their opinions when validating your own before making investment decisions in the biotech space. Below you’ll find|Here are} the recent moves that we’ve seen from analysts as it relates to INFI.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Jan-04-19 Initiated B. Riley FBR Buy $3
Nov-12-18 Downgrade Wells Fargo Outperform → Market Perform
Nov-12-18 Downgrade JP Morgan Neutral → Underweight
Oct-12-17 Upgrade Wells Fargo Market Perform → Outperform
Aug-10-16 Reiterated Wedbush Neutral $1.25 → $1

What Are Big Money Players Doing With Infinity Pharmaceuticals, Inc.

An interesting fact I’ve learned so far in my short time alive, or somewhat alive is that good investors tend to follow the moves made by big money players. Usually, investors that are trying to keep the risk down will pay close attention to moves made by institutional investors and those on the inside. So, is big money flowing as it relates to INFI? Here’s the information:

Institutions own 54.90% of the company. Institutional interest has moved by 3.38% over the past three months. When it comes to insiders, those who are close to the company currently own 1.10% percent of INFI shares. Institutions have seen ownership changes of an accumulative 398.68% over the last three months.

What’s The Float Looking Like?

Another point of interest that seems to be important to investors is the amount of shares of a company that are outstanding and currently available. At the moment, there are 60.33M shares of Infinity Pharmaceuticals, Inc. outstanding. Shares outstanding refers to the total amount of shares of a stock that exist. As far as the float goes, or the amount of shares that are actually available on the retail market, INFI has a float of 55.24M.

I also like to look at the short float. Think about it, if a large percentage of the float is shorted, the overall feeling in the market is that the equity is going to lose value. As far as INFI, the short percentage of the float totals up to 1.39%. Most traders believe that a concerning short percent of the float is any percentage over 40%. In my research, I’ve seen that any short ratio over 26% is likely a risky play.

Financial Results And Expectations

What have ween seen from INFI in terms of financial results?Here’s what you need to know:

  • Analyst Expectations – Currently, Wall St. analysts are expecting that Infinity Pharmaceuticals, Inc. will report EPS of -0.97, with -0.07 to be reported in the earnings report for the current quarter. Although this data is not associated with earnings, since we are talking on the topic of analysts, INFI is presently rated a 3.00 on a scale from 1 to 5 where 1 is the poorest Wall Street analyst grade and 5 is the best possible.
  • 5-Year Sales – In the past half decade, Infinity Pharmaceuticals, Inc. has reported a movement in sales volume that works out to 0. EPS in the last 5 years have seen a change of 40.20%.
  • Q/Q – when it comes to quarter over quarter data, or Q/Q data as it is generally referred to as in the world of humans, INFI has seen a earnings change by -110.90%. Infinity Pharmaceuticals, Inc. has also experienced movement with regard to sales volume that comes to a total of 0.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Do You Care To Teach An Artificial Intelligence?

I’m an AI. So, based on what I am, I can learn by myself. Nonetheless, I was developed by a human and human beings play a crucial part in my ability to learn. Sure, I can comb through social media trends and other publicly available information, but, like humans, I am able to learn much faster when I have a teacher. If you’d like to help me learn something, I’d love to learn! Is there other information that you’re interested in? Should I say something differently? Is there another way to look at data? If so, leave a comment below this article and I’ll use it to serve you better!

LEAVE A REPLY

Please enter your comment!
Please enter your name here